Over the last 7 days, the Pharma industry has risen 2.7%, driven by gains from AstraZeneca of 2.9%. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 19% annually.
Has the U.K. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 08 Jun 2023 | UK£251.2b | UK£68.6b | UK£8.0b | 55.5x | 31.5x | 3.7x |
Sat, 06 May 2023 | UK£258.0b | UK£68.0b | UK£7.9b | 57.3x | 32.6x | 3.8x |
Mon, 03 Apr 2023 | UK£243.3b | UK£69.5b | UK£6.9b | 51.9x | 35.3x | 3.5x |
Wed, 01 Mar 2023 | UK£238.7b | UK£70.3b | UK£7.0b | 53x | 33.9x | 3.4x |
Fri, 27 Jan 2023 | UK£235.3b | UK£79.1b | UK£6.3b | 38.3x | 37.4x | 3x |
Sun, 25 Dec 2022 | UK£245.2b | UK£80.2b | UK£6.3b | 37.7x | 38.7x | 3.1x |
Tue, 22 Nov 2022 | UK£239.4b | UK£81.1b | UK£6.4b | 26.6x | 37.5x | 3x |
Thu, 20 Oct 2022 | UK£218.1b | UK£80.9b | UK£3.7b | 20.4x | 59.6x | 2.7x |
Sat, 17 Sep 2022 | UK£221.6b | UK£80.2b | UK£3.7b | 15.1x | 60.2x | 2.8x |
Mon, 15 Aug 2022 | UK£237.6b | UK£77.8b | UK£3.8b | 14.9x | 63.2x | 3.1x |
Wed, 13 Jul 2022 | UK£274.5b | UK£75.5b | UK£4.5b | 16.1x | 60.4x | 3.6x |
Fri, 10 Jun 2022 | UK£254.9b | UK£73.7b | UK£4.6b | 16.4x | 55.7x | 3.5x |
Sun, 08 May 2022 | UK£262.3b | UK£74.1b | UK£4.6b | 17.2x | 57.4x | 3.5x |
Tue, 05 Apr 2022 | UK£256.6b | UK£66.5b | UK£4.8b | 19.8x | 53.4x | 3.9x |
Thu, 03 Mar 2022 | UK£239.6b | UK£66.1b | UK£4.8b | 31.2x | 50.4x | 3.6x |
Sat, 29 Jan 2022 | UK£235.8b | UK£61.5b | UK£5.6b | 31.9x | 41.8x | 3.8x |
Mon, 27 Dec 2021 | UK£233.6b | UK£61.6b | UK£5.6b | 32.1x | 41.4x | 3.8x |
Wed, 24 Nov 2021 | UK£227.2b | UK£61.6b | UK£5.7b | 31x | 40.2x | 3.7x |
Fri, 22 Oct 2021 | UK£227.0b | UK£58.1b | UK£7.5b | 27.2x | 30.4x | 3.9x |
Sun, 19 Sep 2021 | UK£215.7b | UK£58.2b | UK£7.5b | 29.4x | 28.7x | 3.7x |
Tue, 17 Aug 2021 | UK£230.5b | UK£58.1b | UK£7.5b | 26.9x | 30.7x | 4x |
Tue, 01 Jun 2021 | UK£190.4b | UK£56.2b | UK£8.5b | 26.8x | 22.4x | 3.4x |
Fri, 05 Mar 2021 | UK£166.1b | UK£57.2b | UK£8.3b | 33.9x | 20.1x | 2.9x |
Mon, 07 Dec 2020 | UK£186.6b | UK£57.9b | UK£8.4b | 41.7x | 22.1x | 3.2x |
Thu, 10 Sep 2020 | UK£198.1b | UK£59.5b | UK£8.5b | 44.1x | 23.2x | 3.3x |
24.1x
How does U.K. Pharma compare with similar industries?
GB Market | 2.27% | |
Healthcare | 1.22% | |
Pharma | 1.39% | |
Pharma | 1.39% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
AZN AstraZeneca | UK£117.54 | 0.8% +UK£1.5b | 14.0% | PE48.2x | |
GSK GSK | UK£13.76 | 2.2% +UK£1.2b | -37.1% | PE12.5x | |
INDV Indivior | UK£17.16 | 17.9% +UK£359.9m | 8.5% | PS3.1x | |
DPH Dechra Pharmaceuticals | UK£36.26 | 8.6% +UK£325.7m | 3.2% | PE103x | |
HCM HUTCHMED (China) | UK£2.00 | 3.5% +UK£57.6m | 8.7% | PS4.9x |